Public Policy

The first few weeks of 2021 have brought numerous changes to the federal policy landscape, including the beginning of the new Biden Administration, a new Congress with a Democratic majority in both the Senate and the House of Representatives, and the deadly January 6 attack on the U.S. Capitol and its fallout.  While these events... Read More

Federal laws and policies have a major influence on genetics and genomics research and translation to advances in the clinic and the broader society. It is therefore imperative for ASHG to have a strong voice in how such laws and policies are developed and implemented. Recognizing this, the Society’s public policy and advocacy agenda has... Read More

On September 25, ASHG hosted a virtual Forum with several members of the International Commission on the Clinical Use of Human Germline Genome Editing. The Forum was chaired by Charles Rotimi of NIH, and speakers shared findings from the Commission’s final report on Heritable Human Genome Editing (HHGE), which was released earlier that month. The... Read More

Each year, Congress is tasked with setting budgets across the federal government, including for the National Institutes of Health (NIH), before October 1, the beginning of the new fiscal year. However, this month we passed the October 1 deadline without Congress passing legislation to accomplish this for Fiscal Year 2021. This means that the size... Read More

ASHG remains committed to its vision that people everywhere realize the benefits of human genetics and genomics research. It is imperative for participation in genetics and genomics research to reflect humanity’s diversity. In engaging with vulnerable populations, it is essential that researchers guard against harm resulting from their participation. Related: Comment to House leaders on... Read More